Sawyer & Company Inc purchased a new position in Abbott Laboratories (NYSE:ABT - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 13,321 shares of the healthcare product maker's stock, valued